The Efficacy an Safety of Crizotinib in Patients With ROS1 Positive Advanced Stage NSCLC:The Real-world Experince from Turkey


Kılıçkap S., Ölmez Ö. F. , Çiçin İ., Demirci U., Alan Ö., Çabuk D., ...Daha Fazla

European Society for Medical Onkology 2018 Congress, Munich, Almanya, 19 - 23 Ekim 2018